Analysis of risk factors early recurrence in Hodgkin lymphoma (part 2): test sample

Search criteria individual prediction led us to create a model that allows to estimate for each treated patients, the percentage probability of return of the disease. The model is developed for ABVD-containing chemotherapy regimen. Verification analysis confirmed the role of the individual criteria for the prediction ВЕАСОРР-containing chemotherapy regimens. Adequate level of the index individual forecast can be regarded as values ​​ranging from 0% to 4%, with higher rates of recurrence index in patients with treatment ВЕАСОРР great. A high percentage of relapses (68.2%) in the group with more than 50% chance of early recurrence and poor - a group with less than 50% probability (6.5%) indicate adequate performance classification of the individual prognosis of the program ВЕАСОРР. Adequate level of the index of individual prognosis for patients with treatment CEA/ABVD can assume values ranging from 0% to 4%, perhaps 5-49%. The patients with the index range 50-94% chance of recurrence increases. Now you can estimate the probability of recurrence for each of the treated patients is of interest to oncology, and radiation therapists who treat Hodgkin's lymphoma.